Teladoc Health's Q3 2023 earnings reflect a solid financial performance with revenue reaching $660.2 million, an 8% increase year-over-year. The company also reported strong operating cash flow and made progress in expanding its virtual care offerings.
Revenue increased by 8% year-over-year to $660.2 million.
Operating cash flow was $105.6 million, with a free cash flow of $68.0 million.
Net loss was $57.1 million, equating to $0.35 per share.
Adjusted EBITDA increased 73% year-over-year to $88.8 million.
Teladoc Health anticipates revenue between $658 and $683 million and adjusted EBITDA between $107 and $117 million for Q4 2023. For the full year 2023, revenue is expected to range from $2.6 to $2.625 billion with adjusted EBITDA between $320 and $330 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance